Radio Compass Phisper | Pharmaceutical Phisper at Pharmacompass.com

Incyte’s skin cancer therapy bags FDA nod; Biogen’s ALS drug data insufficient, says panel

Impressions: 633

The US Food and Drug Administration (FDA) has granted accelerated approval to Incyte’s monoclonal antibody Zynyz (retifanlimab) as a treatment for a rare and aggressive type of skin cancer known as Merkel cell carcinoma.A panel of external expe...

#Phispers by PharmaCompass

23 Mar 2023

Share

Pfizer to buy Seagen for US$ 43 bn; Sanofi to acquire Provention Bio for type 1 diabetes med

Impressions: 1205

Biotech M&As picked up this week as Pfizer announced the acquisition of cancer treatment expert Seagen for US$ 43 billion and Sanofi said it will acquire Provention Bio for US$ 2.9 billion.In approvals, Pfizer’s nasal spray for migraine –...

#Phispers by PharmaCompass

16 Mar 2023

Share

Contaminated syrups caused deaths, confirms CDC; Roche, Exelixis’ drug combo fails kidney cancer trial

Impressions: 709

An investigation by the US Center for Disease Control and Prevention (CDC) and Gambian scientists has concluded that contaminated cough and paracetamol syrups imported into Gambia caused the deaths of 70 children due to acute kidney injury. The India...

#Phispers by PharmaCompass

09 Mar 2023

Share

Pfizer in talks to buy Seagen; FDA panel backs Pfizer, GSK’s RSV vaccines

Impressions: 876

Pfizer is in early-stage talks to acquire cancer-focused biotech Seagen for over US$ 30 billion. A panel of external experts to the US Food and Drug Administration (FDA) has backed both GSK and Pfizer’s respiratory syncytial virus (RSV) vaccine...

#Phispers by PharmaCompass

02 Mar 2023

Share

FDA okays first geographic atrophy med; Pfizer’s maternal RSV shot bags priority review

Impressions: 839

The US Food and Drug Administration (FDA) saw a flurry of approvals this week. The agency has approved Apellis Pharmaceuticals’ drug Syfovre (pegcetacoplan). This is the first-ever treatment for geographic atrophy, a major cause of blindness gl...

#Phispers by PharmaCompass

23 Feb 2023

Share

‘GSK kept mum about Zantac cancer risks for decades’; Sun Pharma recalls 34,000 bottles of BP med

Impressions: 2418

A damning report brought out by Bloomberg has said GSK’s scientists knew for decades about the cancer risks associated with its popular heartburn drug Zantac but the drugmaker chose to keep quiet about them. There was good news on GSK’s J...

#Phispers by PharmaCompass

16 Feb 2023

Share

Drugmakers to face Covid cliff in 2023; Gilead’s Trodelvy approved for breast cancer

Impressions: 645

As 2022 results pour in and the pandemic recedes, drugmakers who made steep profits through the sale of Covid-19 products over the last two years have forecast a sharp decline in sales of their vaccines, therapies and kits this year.The US Food an...

#Phispers by PharmaCompass

09 Feb 2023

Share

Pfizer crosses US$ 100 billion in 2022 sales; FDA okays GSK’s anemia med for CKD patients on dialysis

Impressions: 658

Covid-19 products – Comirnaty and Paxlovid – have helped Pfizer cross US$ 100 billion in 2022 sales. With the pandemic receding, the drugmaker expects its turnover to drop 33 percent this year.GSK’s drug — Jesduvroq — ha...

#Phispers by PharmaCompass

02 Feb 2023

Share

WHO expands cough syrup deaths probe; FDA rejects Lilly’s accelerated nod request for Alzheimer’s drug

Impressions: 2005

The World Health Organization (WHO) has expanded its probe into cough syrup deaths to four other nations, and has also found support from the FDA in the case.The US Food and Drug Administration (FDA) has rejected Eli Lilly’s bid for an accelera...

#Phispers by PharmaCompass

26 Jan 2023

Share

Three Indian drugmakers receive FDA’s Form 483; Merck to remove potential carcinogen from diabetes drugs

Impressions: 1253

Last week, the US Food and Drug Administration (FDA) had flagged problems at manufacturing facilities of Intas and Sun Pharma. This week, three other Indian drugmakers – Lupin, Aurobindo Pharma and Granules India – have received the agenc...

#Phispers by PharmaCompass

19 Jan 2023

Share

Find the Radio Compass Phisper of latest pharmaceutical industry information on PharmaCompass.com

Weekly News Recap #Phispers

Incyte’s skin cancer therapy bags FDA nod; Biogen’s ALS drug data insufficient, says panel

Pfizer to buy Seagen for US$ 43 bn; Sanofi to acquire Provention Bio for type 1 diabetes med

Contaminated syrups caused deaths, confirms CDC; Roche, Exelixis’ drug combo fails kidney cancer trial

Pfizer in talks to buy Seagen; FDA panel backs Pfizer, GSK’s RSV vaccines

FDA okays first geographic atrophy med; Pfizer’s maternal RSV shot bags priority review

‘GSK kept mum about Zantac cancer risks for decades’; Sun Pharma recalls 34,000 bottles of BP med

Drugmakers to face Covid cliff in 2023; Gilead’s Trodelvy approved for breast cancer

Pfizer crosses US$ 100 billion in 2022 sales; FDA okays GSK’s anemia med for CKD patients on dialysis

WHO expands cough syrup deaths probe; FDA rejects Lilly’s accelerated nod request for Alzheimer’s drug

Three Indian drugmakers receive FDA’s Form 483; Merck to remove potential carcinogen from diabetes drugs